Suspected YF-AND after yellow fever vaccination in Finland

Anne J Jääskeläinen; Eili Huhtamo; Reetta Kivioja; Cristina Domingo; Sirkka Vene; Hannimari Kallio-Kokko; Matthias Niedrig; Pentti J Tienari; Olli Vapalahti

doi:10.1016/j.jcv.2014.08.022

Suspected YF-AND after yellow fever vaccination in Finland

J Clin Virol. 2014 Nov;61(3):444-7. doi: 10.1016/j.jcv.2014.08.022. Epub 2014 Sep 3.

Authors

Anne J Jääskeläinen¹, Eili Huhtamo², Reetta Kivioja³, Cristina Domingo⁴, Sirkka Vene⁵, Hannimari Kallio-Kokko⁶, Matthias Niedrig⁴, Pentti J Tienari³, Olli Vapalahti⁷

Affiliations

¹ HUSLAB, Department of Virology and Immunology, Helsinki University Central Hospital, Finland; Haartman Institute, Department of Virology, University of Helsinki, Finland. Electronic address: anne.jaaskelainen@helsinki.fi.
² Haartman Institute, Department of Virology, University of Helsinki, Finland.
³ Department of Neurology, Helsinki University Central Hospital, and Molecular Neurology, Research Programs Unit, Biomedicum, University of Helsinki, Helsinki, Finland.
⁴ Centre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses, Robert Koch Institute, Berlin, Germany.
⁵ Public Health Agency of Sweden, Solna, Sweden.
⁶ HUSLAB, Department of Virology and Immunology, Helsinki University Central Hospital, Finland; Haartman Institute, Department of Virology, University of Helsinki, Finland.
⁷ HUSLAB, Department of Virology and Immunology, Helsinki University Central Hospital, Finland; Haartman Institute, Department of Virology, University of Helsinki, Finland; Faculty of Veterinary Medicine, Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.

PMID: 25223921
DOI: 10.1016/j.jcv.2014.08.022

Abstract

Yellow fever (YF) vaccine is considered safe but vaccine-associated complications have also been encountered. We report neurological symptoms after YF-vaccination in a previously healthy Finnish male. Other concomitant infections or causes for the symptoms could not be identified.

Keywords: Adverse reaction; Vaccination; Yellow fever.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Viral / blood
Finland
Humans
Immunoglobulin G / blood
Immunoglobulin M / blood
Male
Middle Aged
RNA, Viral / genetics
RNA, Viral / isolation & purification
Reverse Transcriptase Polymerase Chain Reaction
Time Factors
Vaccination / adverse effects*
Yellow Fever / chemically induced*
Yellow Fever / diagnosis*
Yellow Fever / prevention & control
Yellow Fever Vaccine / administration & dosage*
Yellow Fever Vaccine / adverse effects*
Yellow fever virus / isolation & purification

Substances

Antibodies, Viral
Immunoglobulin G
Immunoglobulin M
RNA, Viral
Yellow Fever Vaccine